Results for the Third Quarter 2023

Sales for the third quarter ended at MNOK 124 (MNOK 117), an increase of 6.5%. Sales YTD September ended at MNOK 391 (MNOK 350), an increase of 11.6%

Currency neutral sales of own products was down 5.6% for the quarter and up 1.2% YTD September. Operating profit (EBIT) for the quarter ended at MNOK 34 giving a 27.0% EBIT margin (MNOK 34, a 29.2% margin). YTD September EBIT is up 4.2% and ended at MNOK 109, giving a 27.9% margin (MNOK 105, a 29.9% margin).

Download the full presentation and report, and watch the video recording from the webinar below.

Quarterly Report Q3 2023

Medistim ASA Q3 2023 Presentation